Literature DB >> 4092200

Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.

S Kaplan, C Sessa, R Joss, J P Obrecht, P Siegenthaler, F Cavalli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 4092200

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  2 in total

1.  Phase II trial of 4' deoxydoxorubicin (DXDX) for unresectable non-small cell bronchogenic carcinoma. An Illinois Cancer Council study.

Authors:  C Rose; T E Lad; L J Kilton; J Schor; S T Rosen; A H Rossof; R R Blough; C M Johnson
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

Review 2.  Anthracycline analogs: the past, present, and future.

Authors:  R B Weiss; G Sarosy; K Clagett-Carr; M Russo; B Leyland-Jones
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.